136 related articles for article (PubMed ID: 23097970)
1. Comparing two techniques of panretinal photocoagulation on visual acuity on patients with proliferative diabetic retinopathy.
Kovacic Z; Ivanisevic M; Bojic L; Hrgovic Z; Lesin M; Kurelovic D
Med Arch; 2012; 66(5):321-3. PubMed ID: 23097970
[TBL] [Abstract][Full Text] [Related]
2. Extended targeted retinal photocoagulation versus conventional pan-retinal photocoagulation for proliferative diabetic retinopathy in a randomized clinical trial.
Nikkhah H; Ghazi H; Razzaghi MR; Karimi S; Ramezani A; Soheilian M
Int Ophthalmol; 2018 Feb; 38(1):313-321. PubMed ID: 28168567
[TBL] [Abstract][Full Text] [Related]
3. [The loss of visual field after proliferative diabetic retinopathy treatment with two different techniques of panretinal photocoagulation].
Kovacić Z; Ivanisević M; Karelović D
Acta Med Croatica; 2007 Apr; 61(2):149-52. PubMed ID: 17585469
[TBL] [Abstract][Full Text] [Related]
4. Combined modified grid and panretinal photocoagulation for diffuse diabetic macular edema and proliferative diabetic retinopathy.
Lee CM; Olk RJ; Akduman L
Ophthalmic Surg Lasers; 2000; 31(4):292-300. PubMed ID: 10928666
[TBL] [Abstract][Full Text] [Related]
5. Light panretinal photocoagulation (LPRP) versus classic panretinal photocoagulation (CPRP) in proliferative diabetic retinopathy.
Bandello F; Brancato R; Menchini U; Virgili G; Lanzetta P; Ferrari E; Incorvaia C
Semin Ophthalmol; 2001 Mar; 16(1):12-8. PubMed ID: 15487693
[TBL] [Abstract][Full Text] [Related]
6. Long-term visual outcome in proliferative diabetic retinopathy patients after panretinal photocoagulation.
Dogru M; Nakamura M; Inoue M; Yamamoto M
Jpn J Ophthalmol; 1999; 43(3):217-24. PubMed ID: 10413257
[TBL] [Abstract][Full Text] [Related]
7. Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Jampol LM; Melia M; Peters MA; Rauser ME;
Ophthalmology; 2017 Apr; 124(4):431-439. PubMed ID: 28161147
[TBL] [Abstract][Full Text] [Related]
8. The effect of photocoagulation on visual acuity in diabetic patients suffering from diabetic macular edema and diabetic retinopathy.
Ilavska M
Bratisl Lek Listy; 2009; 110(7):419-22. PubMed ID: 19711829
[TBL] [Abstract][Full Text] [Related]
9. Quantifying alterations of macular thickness before and after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision.
Shimura M; Yasuda K; Nakazawa T; Kano T; Ohta S; Tamai M
Ophthalmology; 2003 Dec; 110(12):2386-94. PubMed ID: 14644723
[TBL] [Abstract][Full Text] [Related]
10. Severe proliferative diabetic retinopathy treated with vitrectomy or panretinal photocoagulation: a monocenter randomized controlled clinical trial.
Avitabile T; Bonfiglio V; Castiglione F; Castaing M; Contarino F; Mistretta A
Can J Ophthalmol; 2011 Aug; 46(4):345-51. PubMed ID: 21816255
[TBL] [Abstract][Full Text] [Related]
11. Reading deficits in diabetic patients treated with panretinal photocoagulation and good visual acuity.
Omari A; Niziol LM; Gardner TW
Acta Ophthalmol; 2019 Nov; 97(7):e1013-e1018. PubMed ID: 30968579
[TBL] [Abstract][Full Text] [Related]
12. Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
; Gross JG; Glassman AR; Jampol LM; Inusah S; Aiello LP; Antoszyk AN; Baker CW; Berger BB; Bressler NM; Browning D; Elman MJ; Ferris FL; Friedman SM; Marcus DM; Melia M; Stockdale CR; Sun JK; Beck RW
JAMA; 2015 Nov; 314(20):2137-2146. PubMed ID: 26565927
[TBL] [Abstract][Full Text] [Related]
13. Panretinal photocoagulation combined with intravitreal bevacizumab in high-risk proliferative diabetic retinopathy.
Cho WB; Oh SB; Moon JW; Kim HC
Retina; 2009 Apr; 29(4):516-22. PubMed ID: 19262436
[TBL] [Abstract][Full Text] [Related]
14. Panretinal photocoagulation and intravitreal triamcinolone acetonide for the management of proliferative diabetic retinopathy with macular edema.
Zein WM; Noureddin BN; Jurdi FA; Schakal A; Bashshur ZF
Retina; 2006 Feb; 26(2):137-42. PubMed ID: 16467667
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of post-treatment retinopathy after panretinal photocoagulation for proliferative diabetic retinopathy in type 1 diabetes.
Bek T; Kjaergaard J
Eur J Ophthalmol; 2004; 14(6):538-42. PubMed ID: 15638104
[TBL] [Abstract][Full Text] [Related]
16. Changes in the Macular Ganglion Cell Complex Thickness and Central Macular Thickness after Argon Laser Panretinal Photocoagulation.
Demirok G; Kocamaz MF; Topalak Y; Altay Y; Tabakci B; Şengün A
Semin Ophthalmol; 2017; 32(6):759-763. PubMed ID: 27715375
[TBL] [Abstract][Full Text] [Related]
17. Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study).
Figueira J; Fletcher E; Massin P; Silva R; Bandello F; Midena E; Varano M; Sivaprasad S; Eleftheriadis H; Menon G; Amaro M; Ayello Scheer S; Creuzot-Garcher C; Nascimento J; Alves D; Nunes S; Lobo C; Cunha-Vaz J;
Ophthalmology; 2018 May; 125(5):691-700. PubMed ID: 29395119
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal bevacizumab (Avastin) prevention of panretinal photocoagulation-induced complications in patients with severe proliferative diabetic retinopathy.
Mason JO; Yunker JJ; Vail R; McGwin G
Retina; 2008 Oct; 28(9):1319-24. PubMed ID: 18667958
[TBL] [Abstract][Full Text] [Related]
19. [Observation on clinical effects of panretinal coagulation for diabetic retinopathy].
Qian Z; Zhu L; Zhao C
Yan Ke Xue Bao; 2002 Jun; 18(2):99-101. PubMed ID: 15510646
[TBL] [Abstract][Full Text] [Related]
20. Diabetic macular edema following panretinal photocoagulation.
Falavarjani KG; Modarres M; Nazari H; Naseripour M; Parvaresh MM
Arch Ophthalmol; 2010 Feb; 128(2):262; author reply 262. PubMed ID: 20142560
[No Abstract] [Full Text] [Related]
[Next] [New Search]
